scholarly article | Q13442814 |
P50 | author | Michel P. Coleman | Q54006941 |
Chris Bailey | Q59032168 | ||
Audrey Bonaventure | Q84195878 | ||
P2093 | author name string | Claudia Allemani | |
Hannah K Weir | |||
Rhea Harewood | |||
Sherri L Stewart | |||
Lisa C Richardson | |||
Angela R Moore | |||
CONCORD Working Group (US members) | |||
P2860 | cites work | Acute myeloid leukemia in the older adults | Q26740584 |
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia | Q28140129 | ||
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). | Q30873972 | ||
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications | Q30891132 | ||
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. | Q33994320 | ||
Adolescents and young adults with acute lymphoblastic leukemia | Q34159337 | ||
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions | Q34360414 | ||
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma | Q34440364 | ||
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group | Q34609661 | ||
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study | Q35832484 | ||
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization | Q35845470 | ||
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study | Q36579101 | ||
Inequalities in US Life Expectancy by Area Unemployment Level, 1990-2010 | Q36747729 | ||
Comparison of survival outcomes among cancer patients treated in and out of clinical trials | Q37696455 | ||
Cancer survival: global surveillance will stimulate health policy and improve equity | Q38172320 | ||
Life tables for world-wide comparison of relative survival for cancer (CONCORD study). | Q38452520 | ||
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States) | Q38465499 | ||
Leukaemia 'firsts' in cancer research and treatment | Q38748648 | ||
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. | Q40727176 | ||
Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing? | Q44684119 | ||
Is race really a negative prognostic factor for cancer? | Q44975348 | ||
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group | Q46847866 | ||
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. | Q48507831 | ||
On Estimation in Relative Survival | Q61860450 | ||
Standard cancer patient population for age standardising survival ratios | Q80799769 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
P1104 | number of pages | 12 | |
P304 | page(s) | 3856-3867 | |
P577 | publication date | 2018-10-21 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009 | |
P478 | volume | 124 |
Search more.